Maxwell Biomedical

Maxwell Biomedical is a development-stage, science-driven, innovative medical technology company with top-tier talent, dedicated to providing long-term solutions for patients with atrial fibrillation. Maxwell is developing a first-of-its-kind atrial pacing device that can automatically detect AFib and deliver SRT imperceptibly to restore and maintain normal heart rhythm. Device monitoring and cloud connectivity ensure proactive and continuous patient care and management. Maxwell Biomedical was founded in 2019 and is headquartered in San Diego, California.